Coronary heart disease secondary prevention influenza vaccination: Difference between revisions
Jump to navigation
Jump to search
Esther Lee (talk | contribs) (/* ACC / AHA 2012 Guidelines - Coronary Heart Disease - Secondary Prevention through Influenza Vaccination (DO NOT EDIT) {{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Pre...) |
Esther Lee (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
== Overview == | == Overview == | ||
==Influenza Vaccination== | ==Influenza Vaccination== | ||
== | ==2011 AHA/ACCF Guidelines for Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease (DO NOT EDIT) <ref name="pmid22052934">{{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. | journal=Circulation | year= 2011 | volume= 124 | issue= 22 | pages= 2458-73 | pmid=22052934 | doi=10.1161/CIR.0b013e318235eb4d | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22052934 }} </ref>== | ||
===Influenza Vaccination (DO NOT EDIT) <ref name="pmid22052934">{{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. | journal=Circulation | year= 2011 | volume= 124 | issue= 22 | pages= 2458-73 | pmid=22052934 | doi=10.1161/CIR.0b013e318235eb4d | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22052934 }} </ref>=== | |||
{|class="wikitable" | {|class="wikitable" | ||
Line 11: | Line 13: | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | | colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Patients with cardiovascular disease should have an annual influenza vaccination. ([[ACC AHA guidelines classification scheme#Level of Evidence| B]])<nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Patients with cardiovascular disease should have an annual influenza vaccination. <ref name="pmid14683739">{{cite journal |author=Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B |title=Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study |journal=Eur. Heart J. |volume=25 |issue=1 |pages=25–31 |year=2004 |month=January |pmid=14683739 |doi= |url=}}</ref><ref name="pmid18187561">{{cite journal |author=Ciszewski A, Bilinska ZT, Brydak LB, ''et al.'' |title=Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study |journal=Eur. Heart J. |volume=29 |issue=11 |pages=1350–8 |year=2008 |month=June |pmid=18187561 |doi=10.1093/eurheartj/ehm581 |url=}}</ref><ref name="pmid16982936">{{cite journal |author=Davis MM, Taubert K, Benin AL, ''et al.'' |title=Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology |journal=Circulation |volume=114 |issue=14 |pages=1549–53 |year=2006 |month=October |pmid=16982936 |doi=10.1161/CIRCULATIONAHA.106.178242 |url=}}</ref><ref name="pmid20360671">{{cite journal |author=Lindsey NP, Staples JE, Lehman JA, Fischer M |title=Surveillance for human West Nile virus disease - United States, 1999-2008 |journal=MMWR Surveill Summ |volume=59 |issue=2 |pages=1–17 |year=2010 |month=April |pmid=20360671 |doi= |url=}}</ref> ([[ACC AHA guidelines classification scheme#Level of Evidence|''Level of Evidence: B'']])<nowiki>"</nowiki> | ||
|} | |} | ||
==Sources== | |||
* 2011 AHA/ACCF Guidelines for Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Aterosclerotic Vascular Disease (DO NOT EDIT) <ref name="pmid22052934">{{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. | journal=Circulation | year= 2011 | volume= 124 | issue= 22 | pages= 2458-73 | pmid=22052934 | doi=10.1161/CIR.0b013e318235eb4d | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22052934 }} </ref> | |||
== References == | == References == |
Revision as of 16:59, 14 November 2012
Coronary heart disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Coronary heart disease secondary prevention influenza vaccination On the Web |
American Roentgen Ray Society Images of Coronary heart disease secondary prevention influenza vaccination |
FDA on Coronary heart disease secondary prevention influenza vaccination |
CDC on Coronary heart disease secondary prevention influenza vaccination |
Coronary heart disease secondary prevention influenza vaccination in the news |
Blogs on Coronary heart disease secondary prevention influenza vaccination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Influenza Vaccination
2011 AHA/ACCF Guidelines for Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease (DO NOT EDIT) [1]
Influenza Vaccination (DO NOT EDIT) [1]
Class I |
"1. Patients with cardiovascular disease should have an annual influenza vaccination. [2][3][4][5] (Level of Evidence: B)" |
Sources
- 2011 AHA/ACCF Guidelines for Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Aterosclerotic Vascular Disease (DO NOT EDIT) [1]
References
- ↑ 1.0 1.1 1.2 Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA; et al. (2011). "AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation". Circulation. 124 (22): 2458–73. doi:10.1161/CIR.0b013e318235eb4d. PMID 22052934.
- ↑ Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B (2004). "Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study". Eur. Heart J. 25 (1): 25–31. PMID 14683739. Unknown parameter
|month=
ignored (help) - ↑ Ciszewski A, Bilinska ZT, Brydak LB; et al. (2008). "Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study". Eur. Heart J. 29 (11): 1350–8. doi:10.1093/eurheartj/ehm581. PMID 18187561. Unknown parameter
|month=
ignored (help) - ↑ Davis MM, Taubert K, Benin AL; et al. (2006). "Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology". Circulation. 114 (14): 1549–53. doi:10.1161/CIRCULATIONAHA.106.178242. PMID 16982936. Unknown parameter
|month=
ignored (help) - ↑ Lindsey NP, Staples JE, Lehman JA, Fischer M (2010). "Surveillance for human West Nile virus disease - United States, 1999-2008". MMWR Surveill Summ. 59 (2): 1–17. PMID 20360671. Unknown parameter
|month=
ignored (help)